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ABSTRACT
As a non-metal oxide, yttrium oxide (Y2O3) nanoparticles have numerous applications in
chemical synthesis, mechanical polishing and as additives to drugs, cosmetics, varnishes and
food. Recent data have suggested that these particles are capable of inducing oxidative stress
and cytotoxicity in human endothelial cell lines. To examine the potential mechanisms of
yttrium oxide toxicity, human embryonic kidney (HEK293) cells were exposed to 1, 5, 10, 50 and
100 μM of Y2O3 nanoparticles for 12, 24, 36 or 48 hr. We hypothesized that exposure of HEK293
kidney cells to Y2O3 nanoparticles would be associated with increased evidence of intracellular
oxidative stress and cell death. Our data suggested that exposure to Y2O3 nanoparticles was
associated with time and dose dependent decrease in cell viability and evidence of increased
cellular superoxide levels. Immunoblotting of protein isolates demonstrated that changes in cell
viability were associated with alterations in protein kinase B (Akt), Bax / Bcl-2 and caspase-3
expression. Taken together, these data suggest that Y2O3 nanoparticle exposure may be
associated with diminished cell viability and that these alterations are associated with increased
oxidative stress and alterations in cellular signaling.
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Mechanisms of yttrium oxide toxicity in HEK293 cells

CHAPTER 1

Introduction
Nanoparticles have structural features with at least one dimension in the 1–100 nm
range [1]. Nanoparticles often times possess unique chemical, mechanical, electrical, optical,
magnetic, and biological properties that make them ideal candidates for a variety of novel
commercial and medical applications. Engineered nanoparticles are commonly produced in a
wide variety of types, including metal and metal oxide particles, polymer nanoparticles, and
quantum dots [2]. Current nanoparticle applications include the use of these materials for drug
delivery systems, energy conservation, and consumer products [2]. Although exhibiting
tremendous potential for the development of new materials and processes, it is currently
unclear whether nanomaterials may be toxic to the environment. This gap in our understanding
is important given the rapidly developing commercialization of nanoparticles both here in the
United States and abroad [3].
Exposure to nanoparticles could occur through oral, dermal, inhalation, and injection
routes, all of which could potentially initiate adverse biological reactions [4]. The unique
physiochemical properties of nanoparticles (i.e., shape, particle size, agglomeration state,
crystal structure, chemical composition, surface area, surface chemistry, surface charge, and
porosity) are most likely responsible for the biological activity that occurs in response to
nanoparticle exposure [2]. Specifically, nanoparticles of smaller size have a greater potential for
biological interaction because these particles have a greater surface area per unit mass [5].
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As a non-metal oxide, yttrium oxide (Y2O3) nanoparticles have numerous applications in
chemical synthesis, mechanical polishing and as additives to drugs, cosmetics, varnishes and
food. In recent years, the use of Y2O3 nanoparticles has been extended to biomedical and
biotechnological fields where these particles have been used for the quantification of different
biomolecules and as potential delivery platforms for drug delivery[5].
The effects of Y2O3 nanoparticles on biological systems are not well understood.Y2O3
nanoparticles are able to rescue cells from oxidative stress because of antioxidant properties in
neuron cells. Whether Y2O3 nanoparticles exhibit similar effects in other cell types is not well
understood. Given the possibility that inhaled nanoparticles may penetrate the lungs and
become deposited in extra-pulmonary tissues [6] and the role that the kidneys play in
detoxification of the body, we sought to determine whether exposure to Y2O3 nanoparticle
elicits a toxicological effect on the human embryonic kidney cell line (HEK293). This cell line was
selected for study on the basis of previous reports demonstrating that these cells can be used
to model toxicity in the human kidney [7, 8].
Purpose and hypothesis
The purpose of this study is to assess the toxic effects of yttrium oxide on kidney cells.
We hypothesized that exposure of HEK293 kidney cells to Y2O3 nanoparticles would be
associated with increased evidence of intracellular oxidative stress and cell death. To test this
hypothesis the following two specific aims were pursued:

Specific Aim 1: To determine the toxic dose and time course of HEK293 cell death following
exposure to Y2O3 nanoparticles.
2

Specific Aim 2: To determine if yttrium oxide induced cell death in the HEK293 cell line is
associated with elevations in oxidative stress.

3

CHAPTER 2

Review of literature
Introduction
A review of the relevant literature concerning this study will be presented. The following
areas of interest will be addressed: 1) What is nanotechnology? 2) Potential impact of
nanotechnology, 3) Potential effects of nanoparticles on cellular structure and function, 4)
Yttrium oxide nanoparticles, 5) Regulation of cellular toxicity and apoptosis and 6) Yttrium oxide
toxicity and apoptosis.

What is nanotechnology?
Nanotechnology is the study of manipulating matter on an atomic and molecular scale.
Generally, nanotechnology deals with developing materials or other structures possessing at
least one dimension sized from 1 to 100 nanometers [1]. Nanotechnology is diverse, ranging
from extensions of conventional device physics to completely novel approaches based upon
molecular self-assembly, to developing new materials with dimensions on the nano scale to
investigating whether we can directly control matter on the atomic scale. Nanotechnology
requires the application of fields of science as diverse as surface science, organic chemistry,
molecular biology, and semi-conductor physics. There is much debate on the future
implications of nanotechnology. Nanotechnology may be able to create many new materials
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with a vast range of applications, such as in medicine, biomaterials and energy production. On
the other hand, nanotechnology raises many of the same issues as any new technology,
including concerns about the toxicity and environmental impact of nanomaterials [1].

Potential impact of nanotechnology
There are possible hazards that arise with the development of nanotechnology. The
Center for Responsible Nanotechnology suggests that novel developments could result, among
other things, in untraceable weapons of mass destruction, networked cameras for use by the
government, and weapons developments fast enough to destabilize arms races [9]. One area of
concern regarding the application of nanomaterials is the effect that industrial-scale
manufacturing and use of nanomaterials would have on human health and the environment
[10]. Some groups such as the Center for Responsible Nanotechnology have advocated that
nanotechnology should be specially regulated by governments for these reasons [11]. Others
counter that overregulation would stifle scientific research and the development of innovations
that could greatly benefit mankind [12].
Manufactured nanoparticles display physicochemical characteristics and coatings that
impart upon them unique electrical, thermal, mechanical, and imaging properties that are
highly desirable for applications within the commercial, medical and environmental sectors.
Potential occupational and public exposure to manufactured nanoparticles is expected to
increase dramatically in the near future as more and more consumer products begin to
incorporate the use of nanomaterials [13].
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Potential effects of nanoparticles on cellular structure and function
It is well known that nanoparticles can enter cells and react with subcellular structures
[14]. Whether the cells retains the particles, or whether the particles trigger or catalyze
chemical reactions, depends on the chemical composition and size of the particle [14]. In many
cases, it is thought that the particles are able to freely reside in the cell where they may interact
with different cellular organelles. For example, C60-fullerene particles have been shown to
distribute throughout the cell including inside the nucleus [15]. Experimentally, nanoparticles
have been shown to segregate to the cell membrane, cytoplasm [16, 17], mitochondria [18, 19],
in lipid vesicles [16, 19], on the nuclear membrane [16] and within the nucleus [16, 18]. The
mechanism(s) that control nanoparticle localization within the cell are currently not well
understood.
Additional studies have shown that free radical formation can be triggered by
nanoparticles such as fullerenes, carbon nanotubes, quantum dots, or exhaust emission
particles [20]. The resulting overproduction or the chronic production of reactive oxygen
species (ROS) can damage DNA, proteins and lipids, which then influence cellular processes
[20]. Nanoparticles can also affect the fundamental cell functions and cell physiological
processes like cell proliferation, cell metabolism and cell death [21]. It has been shown that
carbon nanotubes can alter cell proliferation, apoptosis and other aspects of cellular
homeostasis [22]. Interestingly, it appears that these changes are not only concentration
dependent but they also depend on the size and purity of the nanomaterials used [23]. Other
work has indicated that cellular response may also be cell type dependent [21] suggesting that
nanoparticle toxicity is dependent upon a variety of different factors.
6

Yttrium oxide nanoparticles
Recent data have suggested that Y2O3 nanoparticles are able to rescue cells from
oxidative stress-induced cell death in a manner that appears to be dependent upon the
structure of the particle and one that is largely dependent of particle size [24]. It is thought that
this effect may be due to the ability of yttrium oxide particles to protect the cell from oxidative
stress. How this may occur is not well understood as it is possible that the Y2O3 nanoparticles
may act directly as an antioxidant, or, alternatively, they could also inhibit the activity of
enzymes that function to generate reactive oxygen species [24, 25].

Regulation of cellular toxicity and apoptosis
Phosphoinositide signaling is an important signal transduction system in the last decade
or so [26]. It is well accepted that lipid molecules can function as second messengers and that
these molecules may be involved in regulating a wide range of cellular responses. Recent data
suggest that the phosphatidylinositol 3-kinase (PI3-K) plays a key role in cell signaling and that it
is involved in the regulation of cell proliferation, survival, motility and secretion [27, 28]. One
product of the PI3-K molecule is PIP3. PIP3 is an important lipid second messenger, which is
involved in the regulation of downstream PI3-K signaling through its ability to activate other
protein kinases. A diverse group of Ser/Thr kinases are regulated downstream of PI3-K,
including protein kinase C (PKC) and protein kinase B / Akt [28]. Akt is important in the
maintenance of cell survival as it is involved in the regulation of the anti-apoptotic molecules
Bcl-2 and Foxo-1 [29, 30]. The activity of Akt has been shown to be regulated by
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phosphorylation [31]. How yttrium oxide exposure may regulate Akt signaling has, to our
knowledge, not been investigated.
Apoptosis is a mechanism wherein cells die gradually in an orderly fashion. Apoptosis is
regulated by both intrinsic and extrinsic signaling pathway [32]. It is thought that apoptosis is
regulated, at least in part, by members of Bcl-2 family with Bcl-2 functioning to prevent
apoptosis whereas Bax serves to promote apoptosis[33].
The extrinsic apoptosis pathway is activated when cytokines such as TNF-α bind to the
receptors on cell surface [34]. The binding of TNF-α to its receptor results in the recruitment
procaspase-8 to the cell membrane, which leads to the formation of a death inducing signaling
complex. Conversely, activation of intrinsic apoptosis pathway is under the control of
mitochondria and is regulated by elevations in oxidative stress, cell starvation, or changes in the
amount of growth factors [35]. During stressful conditions mitochondria initiate apoptosis by
releasing cytochrome c, which then causes the release of apoptotic protease - activating factor
(Apaf-1) [18]. Apaf-1, in turn, causes the release of caspase-9, which initiates the activation of
other caspases and eventually cell death.
Previous studies have shown that nanoparticles can both induce and prevent apoptosis.
For examples, ceria nanoparticles are able to decrease the amount of reactive oxygen species
seen after glutamate exposure, which has been shown to have a protective effect to cultured
HT22 rodent nerve cells [24]. It is thought that this protective effect is due to the ability of the
ceria nanoparticles to act as free radical scavengers [36]. It has also been demonstrated that
ceria nanoparticles are neuroprotective to adult rat spinal cord neurons. Other work has shown
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that ceria nanoparticles protect against the progression of cardiac dysfunction and remodeling
by attenuation of myocardial oxidative stress [37].
Unlike ceria nanoparticles, carbon nanotubes, iron oxide and titanium oxide nanoparticles have been shown to cause cellular death [38]. Carbon nanotubes (CNTs) are allotropes
of carbon with a cylindrical nanostructure. Nanotubes have been constructed with length-todiameter ratio of up to 132,000,000:1 [39]. These cylindrical carbon molecules have unusual
properties that may be of significant value for use in the electronics, optics and other fields of
materials science and technology. The toxicity of carbon nanotubes has been an important
question in nanotechnology. It has been shown that nanotubes can cross membrane barriers,
and that these materials can induce harmful effects such as inflammatory and fibrotic reactions
[40]. Numerous reports have examined the general toxicity of oxide nanomaterials; however,
little data exist on how these nanomaterials may cause toxicity from a mechanistic perspective
[41].

Yttrium oxide toxicity and apoptosis
Recent data suggest that exposure to Y2O3 nanoparticles can function to rescue cells
from various forms of lethal stress [42]. Whether Y2O3 nanoparticles exhibit toxic or protective
effect appears to depend on particle size, dose, and exposure time [43]. Other work has
demonstrated yttrium oxide-induced apoptosis is governed, at least in part, by particle size. In
this study our main focus is on how different concentrations of similar size yttrium oxide
nanoparticles particles might affect the cellular response in HEK293 cells.
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CHAPTER 3

Mechanisms of yttrium oxide toxicity in HEK 293 cells
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Abstract
As a non-metal oxide, yttrium oxide (Y2O3) nanoparticles have numerous applications in
chemical synthesis, mechanical polishing and as additives to drugs, cosmetics, varnishes and
food. Recent data have suggested that these particles are capable of inducing oxidative stress
and cytotoxicity in human endothelial cell lines. To examine the potential mechanisms of
yttrium oxide toxicity, human embryonic kidney (HEK293) cells were exposed to 1, 5, 10, 50 and
100 μM of Y2O3 nanoparticles for 12, 24, 36 or 48 hr. We hypothesized that exposure of HEK293
kidney cells to Y2O3 nanoparticles would be associated with increased evidence of intracellular
oxidative stress and cell death. Our data suggested that exposure to Y2O3 nanoparticles was
associated with time and dose dependent decreases in cell viability and evidence of increased
cellular superoxide levels. Immunoblotting of protein isolates demonstrated that changes in cell
viability were associated with alterations in protein kinase B (Akt), Bax / Bcl-2 and caspase-3
expression. Taken together, these data suggest that Y2O3 nanoparticle exposure of similar size
with different concentrations may be associated with diminished cell viability and that these
alterations are associated with increased oxidative stress and alterations in cellular signaling.
Key words: Cyto toxicity, nanoparticles, AKT, MTT, oxidative stress, apoptosis.

11

Introduction
Research in the nanosciences is growing at a breathtaking pace. It is anticipated that the
unique properties of nanomaterials and nanoparticles will allow the development of new
products that will be of value in almost every field of human activity [28]. Although very
promising, recent studies examining the biological effects of nanoparticles have demonstrated
that some may exhibit an unexpected degree of toxicity to living organisms and humans [4446].
As a non-metal oxide, Y2O3 nanoparticles have numerous applications in chemical
synthesis, mechanical polishing and as additives to drugs, cosmetics, varnishes and food [47]. In
recent years, the use of Y2O3 nanoparticles has been extended to biomedical and
biotechnological fields where these particles have been used for the quantification of different
biomolecules and as potential delivery platforms for drug delivery [5]. The effects of Y2O3
nanoparticles on biological systems and the effects these nanoparticles may have on different
cell types are not well understood. Given the possibility that inhaled nanoparticles may
penetrate the lungs and become deposited in extra-pulmonary tissues [6] and the role that the
kidneys play in detoxification of the body we sought to determine whether exposure to Y2O3
nanoparticle can cause toxicological effect on the human embryonic kidney cell line (HEK293).
This cell line was selected for study on the basis of previous reports demonstrating that these
cells can be used to model toxicity in the human kidney [7]. To investigate the possible
mechanisms of cytotoxicity, a variety of surrogate parameters were examined including the
analysis of cellular morphology, the generation of reactive oxygen species (ROS), cell viability,
and intracellular signaling. Our data suggest that Y2O3 nanoparticles induce cytotoxicity in
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HEK293 cells in a dose and time dependent manner. This cytotoxicity appears to be associated
with elevation in oxidative stress and activation of AKT, Caspase-3 and up regulation of Bax /
Bcl-2 ratio in dose- dependent manner.

Materials and methods
Materials
HEK293 cells were obtained from American Type Cell Culture (ATCC). DMEM modified
high glucose medium, fetal bovine serum, penicillin streptomycin antibiotics, trypsin, dimethyl
sulfoxide (DMSO), MTT (3-4, 5-Dimethylthiazol-2-yl-2, 5-diphenyltetrazolium bromide), and
Y2O3 nanoparticles were purchased from Sigma-Aldrich (St. Louis, MO, USA). Akt (#9272),
phospho-Akt (Ser473) (#9271), anti-rabbit secondary antibody (#7074) were from Cell Signaling
Technology, Inc., Danvers, MA, USA. Enhanced chemiluminiscence (ECL) western blotting
detection reagent was obtained from Amersham Biosciences (Piscataway, NJ). Restore western
blot stripping buffer was purchased from Pierce (Rockford, IL). All other chemicals were
purchased from Fisher Scientific (Hanover, IL).

Methods
Cell culture and nanoparticles treatment
HEK293 cells were maintained in Dulbecco's modified Eagle's medium (DMEM)/F12
containing 10% heat-inactivated fetal bovine serum, penicillin (100 IU / ml), and streptomycin
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(10 μg / ml). Cells were grown and maintained in 150 cm2 cell culture flasks at 37 °C in a 5% CO2
humidified incubator.
Y2O3 nanoparticles (10 wt. % in water, average diameter 40 nm) were added to the
culture media and dispersed by sonication (100 W x 20 min) before treatment. Potential
agglomeration was assessed by dynamic light scattering using a Horiba LB-55 as outlined by the
manufacturer.

Cell viability assay
Cell

viability

was

measured

by

the

MTT

(3-(4-5-dimethylthiazol-2-yl)-2,

5-

diphenyltetrazolium bromide, Sigma, St. Louis, MO) assay as outlined elsewhere [48]. Briefly,
cells (2 × 104) were seeded in 96-well tissue culture plates in 200 μl of media per well for 24 hr.
At the end of the stabilization period, the medium was removed, and then replaced with serum
free media containing either 1, 5, 10, 50 or 100 μM Y2O3 nanoparticles for either 12, 24, 36, or
48 hr. Experiments were performed in quadruplicate. Negative (untreated) and positive (50 μM
paraquat) controls were included in all experiments. At the appropriate time period, 20 μl of
MTT solution (2 mg / ml) was added to the media and the cells were incubated for 4 hr at 37 °C.
Cells were treated with 200 μl of DMSO and the absorbance was quantified at 570 nm using a
micro plate spectrophotometer (VersaMax, Molecular Devices, and Sunnyvale, CA, USA).
Viability after treatment was expressed relative to the negative controls.
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Dihydroethidium staining
Confluent HEK293 cells were treated with 1, 10 or 100 μM of Y2O3 nanoparticles for 24
hrs, washed with PBS, and 5μM dihydroethidium was added to the medium for 30 min.
Superoxide levels were examined by fluorescent microscopy using an EVOS fluorescent
microscope (Fisher scientific, IL, and USA).

TUNEL staining
Confluent HEK293 cells were treated with 1, 10 or 100 μM of Y2O3 nanoparticles for 24
hrs, washed with PBS, and then fixed with 4% paraformaldehyde. After washing with PBS (pH
7.4), cells were permeabilized with 0.1% sodium citrate and 0.1% Triton X. DNA fragmentation
was determined by TdT-mediated dUTP nick end labeling (TUNEL) as outlined by the
manufacturer. Fluorescent images were obtained using an EVOS fluorescent microscope (Fisher
scientific, IL, USA)

Preparation of protein isolates and immunoblotting
Confluent HEK293 cells were treated with 1, 10 or 100 μM of Y2O3 nanoparticles for 24
hr, washed with PBS and trypsinized as outlined elsewhere [49]. Cells were collected and
pelleted (500 x g for 3 min) and homogenized in TPER (10μl/mg) containing protease and
phosphatase inhibitors for 5 min at 100 W using a PowerGen homogenizer (Fisher Scientific, IL,
USA,). Samples were placed on ice 30 min and vortexed frequently before centrifugation (2,000
x g for 5 min at 4 °C). Protein concentration was determined in triplicate by the Bradford
procedure [50].
15

Forty micrograms of total protein from each sample were separated using 15% SDSPAGE and then transferred onto a nitrocellulose membrane using standard conditions [51].
Membranes were stained with Ponceau S, and the amount of protein quantified by
densitometry to confirm successful transfer of proteins and equal loading of lanes. For
immunodetection, membranes were blocked for 1 hr at room temperature in blocking buffer
(5% non-fat dry milk in TBS-T (20 mM Tris-base, 150 mM NaCl, 0.05% Tween-20), pH 7.6),
serially washed in TBS-T at room temperature and then probed with antibodies overnight at 4 0
C in primary antibody buffer (5% BSA in TBS-T, pH 7.6, primary antibody diluted 1:1000). After
washing in TBS-T (3 X 5 min each) membranes were incubated with an HRP conjugated
secondary antibody in blocking buffer for 1 hr. After removal of the secondary antibody,
membranes were washed (3 X 5 min each) in TBS-T and protein bands were visualized by ECL
reagent. Target protein levels were quantified by AlphaEaseFC image analysis software (Alpha
Innotech, San Leandro, CA, USA) and normalized to glyceraldehyde 3-phosphate
dehydrogenase (GAPDH).

Statistical analysis
Results are presented as mean ± SEM. Data were analyzed by using the Sigma Stat 3.0
Statistical program. Data were analyzed using a two-way ANOVA followed by the StudentNewman-Keuls post-hoc testing where appropriate. A P <0.05 was considered to be statistically
significant.
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RESULTS
Yttrium oxide exposure is associated with cytotoxicity and increased superoxide but not
apoptosis.
Cell viability in response to Y2O3 nanoparticle exposure appeared to decrease in a time
and concentration dependent manner (Figure 1). There is reduced cell viability with Y2O3
nanoparticle concentration of 100 µM at 48 hr. At 24 hr Y2O3 induced cytotoxicity is equal to
that of paraquat. To examine whether exposure to Y2O3 nanoparticles was associated with
changes in the amount of intracellular reactive oxygen species, we repeated the exposure
experiments and then treated the cells with dihydroethidium, which is oxidized to ethidium and
fluoresces in the presence of superoxide [52]. As expected, we observed what appeared to be a
dose-dependent increase in the amount of ethidium reactivity (Figure 2). To determine if
yttrium oxide exposure is associated with cellular apoptosis, we next examined cells that had
been incubated with Y2O3 nanoparticles for the presence of double stranded DNA breakage
using the TUNEL assay. Similar to our findings on cell viability, Y2O3 nanoparticle exposure
appeared to be associated with a slight increase in TUNEL reactivity (Figure 3). To determine if
elevation in oxidative stress is associated with AKT activation, which can be reflected in the
form of cytoplasmic exportation of FOXO-3, we next examined cells that had been incubated
with Y2O3 nanoparticles for the presence of FOXO-3 in cytoplasm. Corresponding to elevation in
oxidative stress, there is translocation of FOXO-3 from the nucleus to the cytoplasm. Taken
together these data suggest that yttrium oxide exposure in HEK293 cells is associated with
diminished cellular viability that may be caused, at least in part, by elevations in superoxide.
17

Yttrium oxide exposure is associated with protein kinase B / Akt phosphorylation.
Compared to observations in the control (untreated cells) the amount of
phosphorylated Akt levels was 17.0 ± 1.8%, 15.7 ± 0.8%, and 27.9 ± 0.8% higher in the HEK293
cells exposed to 1, 10, and 100 μM of Y2O3 nanoparticles, respectively (P < 0.05, Fig 5).

Yttrium oxide exposure is associated with increased caspase-3 cleavage and elevations in the
ratio of Bax / Bcl-2.
Compared to control cells, the cleavage of caspase-3 was 11.52 ± 0.30 % in the HEK293
cells exposed to 10 μM of Y2O3 nanoparticles (P <0.05, Figure 6). Similarly, the ratio of Bax / Bcl2 was 13.39 ± 0.28 %, 8.68 ±0.42% and 11.0 ± 0.36% higher in HEK293 cells exposed to 1, 10,
and 100 μM of yttrium oxide nanoparticles, respectively (P <0.05, Figure 7).
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Discussion
The potentially hazardous effects of nanoparticles are an emerging area of research to
regulatory authorities [53-55]. Although Y2O3 nanoparticles exhibit the potential to act as
antioxidants, whether these particles are cytotoxic is not well understood. Here we examine if
different concentrations of Y2O3 nanoparticles are cytotoxic to HEK293 cells and the potential
mechanism(s) of toxicity, if present. Our data suggest that exposure to Y2O3 nanoparticles
results in diminished cell viability and elevations in cellular oxidative stress.
The results of viability tests showed that cell viability diminished in a concentration and
time dependent fashion. Cytotoxicity appeared to be maximal at a concentration of 100 µM
and after 48 hr (Figure 1). It has been known that the toxicity of nanoparticles is closely related
to the concentration of the particles [56]. Whether a similar cytotoxicity to yttrium oxide
exposure would be observed in other cell types is currently unknown but is worthy of future
investigation.
Similar to what we observed for cell viability, it also appears that increased exposure to
Y2O3 nanoparticles is associated with increases in cellular superoxide levels (Figure 2). It is
thought that superoxide levels are an important regulator of cellular death [57] as excess
superoxide levels have been shown to induce changes in mitochondrial membrane
permeability, which, if allowed to proceed unchecked, can trigger the apoptotic process [58,
59]. How exposure to Y2O3 nanoparticles may cause an increase in cellular superoxide levels is
currently unclear.
Given that elevations in oxidative stress can lead to cellular death [60] we next
examined whether exposure of HEK293 cells to Y2O3 nanoparticles is associated with increases
19

in cellular apoptosis using the TUNEL assay. Consistent with our cell viability assays, we found
that yttrium oxide exposure was associated with evidence of HEK293 apoptosis (Figure 3).
In an effort to understand the potential mechanism(s) responsible for these findings we
next examined how exposure to Y2O3 nanoparticles affected the phosphorylation status of
protein kinase B / Akt. The Akt is serine / threonine kinase, which is involved in the regulation of
cell metabolism and cell death [61]. For these experiments we employed a two - pronged
approach. In the first set of experiments we used HEK293 cells, which stabely expressed a GFP
labeled FOXO-3 protein. Given that the cellular location of FOXO-3 is regulated by Akt activity,
we hypothesized that this cell line would allow us to examine the functionality of Akt signaling
in live cells under real world condition. After treatment of the HEK293 cells with different
concentrations of Y2O3 nanoparticles, we observed what appeared to be an increase in amount
of FOXO-3: GFP that was localized in the cytoplasm (Figure 4). This finding suggests that Y2O3
nanoparticle exposure is associated with increased activation (phosphorylation) of Akt. To
confirm these findings, immunoblotting was performed. As expected, our data suggested that
increased yttrium oxide exposure was associated with increased Akt phosphorylation
(activation) (Figure 5). Given that Akt activation is strongly anti-apoptotic, we interpret these
data to suggest that the phosphorylation of Akt is a compensatory response that is initiated to
stave off the possibility of yttrium oxide-induced apoptosis.
A critical step in the execution of the apoptotic program is the fragmentation of
caspase-3 into its 19- and 17- kDa fragments [62]. Caspases are cysteine-dependent aspartate
specific proteases that function as endonucleases in execution of cell death [62, 63]. Compared
to that observed in the control cells, we found that exposure of HEK293 cells to 10 μM of Y2O3
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nanoparticles was associated with increases in the cleavage of caspase-3 whereas exposure to 1
or 100 μM was not (Figure 6). In an effort to explain this rather curious finding further, we next
examined the ratio of Bax / Bcl-2 following Y2O3 nanoparticle exposure. It has been shown that
cellular function is diminished as the Bax / Bcl-2 ratio increases [64]. Consistent with our cell
viability experiments, we found that exposure to Y2O3 nanoparticles was associated with an
elevation in the ratio of Bax / Bcl-2 (Figure 7).
In conclusion, this study suggests that exposure to yttrium oxide nanoparticles is
associated with diminished cellular viability and increases in cellular superoxide levels and that
these findings may be associated with increased cell death that may be dependent, at least in
part, due to elevations in the Bax / Bcl-2 ratio. Future research examining other pathways or
molecules is needed to better ascertain the exact mechanism(s) by which yttrium oxide
exposure may affect cell function. Given our preliminary findings, additional studies may be
warranted.
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FIGURES

Figure 1. Effect of yttrium oxide nanoparticles on HEK293 viability.
Cell viability was assessed by the MTT assays after exposure to different concentrations of Y 2O3
nanoparticles for 12, 24, 36 or 48 hr. * significantly different from the untreated negative
controls. † Significantly different from paraquat control.
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Figure 2. Exposure to yttrium oxide nanoparticles is associated with elevations in cellular
superoxide levels. Cells were exposed to different concentrations of Y2O3 nanoparticles for 24
hrs prior to incubation with dihydroethidium and visualization under fluorescence (Indicated by
arrow). An increase in the amount of fluorescence is proportional to increase in superoxide
levels. Panel A: Control (no Y2O3), B: 1 μM Y2O3 , C: 10 μM Y2O3, D: 100 μM Y2O3, and E:
Paraquat 50 μM. Cells were imaged at 200 X magnification.
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Figure 3. Exposure to yttrium oxide nanoparticles is associated with increased cellular
apoptosis in HEK293 cells. Cells were exposed to different concentrations of Y 2O3 nanoparticles
for 24 hrs prior to TUNEL staining. An Increase in the amount of fluorescence in the cells
indicates increased cellular apoptosis (Indicated by arrow). Panel A: Control (no Y2O3), B: 1 μM
Y2O3 , C: 10 μM Y2O3, and D: 100 μM Y2O3. Cells were imaged at 200 X magnification.
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Figure 4. Exposure to yttrium oxide nanoparticles is associated with nuclear exportation of
FOXO-3 gene. Cells were exposed to different concentrations of Y 2O3 nanoparticles for 24 hrs
prior to visualization of FOXO-3: GFP under fluorescence (Indicated by arrow). Panel A: Control
(no Y2O3), B: 1 μM Y2O3 , C: 10 μM Y2O3, D: 100 μM Y2O3, and E: Paraquat 50 μM. Cells were
imaged at 400 X magnification.
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Figure 5. Yttrium oxide nanoparticle exposure is associated with the phosphorylation of Akt.
Protein isolates obtained from control and Y2O3 treated cells were analyzed by immunoblotting
for alterations in Akt expression and phosphorylation (Ser473). * Significantly different from
untreated controls.
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Figure 6. Cleaved caspase-3 is activated in HEK293 cells treated with Y2O3.
Protein isolates obtained from control and Y2O3 treated cells were analyzed by immunoblotting
for caspase-3 cleavage. * Significantly different from untreated controls.
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Figure 7. Upregulation of Bax/Bcl-2 in HEK293 cells treated with Y2O3.
Protein isolates obtained from control and Y2O3 treated cells were analyzed by immunoblotting
for alterations in the ratio of Bax/Bcl-2. * Significantly different from untreated controls.
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CHAPTER 4

Conclusions
1. Yttrium oxide nanoparticles induce cytotoxicity in HEK293 cells in a dose and time
dependent manner.

2. Yttrium oxide nanoparticles increase cellular superoxide levels in HEK293 cells in a dose
dependent manner.
3. Yttrium oxide nanoparticle exposure (100 μM) is associated with protein kinase B / Akt
phoshorylation (activation) in HEK293 cells.
4. Yttrium oxide nanoparticle exposure (10 μM) is associated with increased cleavage of
caspase-3 in HEK293 cells.
5. Yttrium oxide nanoparticle exposure is associated with elevations in the Bax / Bcl-2 ratio
in HEK293 cells.
Taken together these data suggest that yttrium oxide exposure induces cytotoxicity in
HEK293 cells in time and dose dependent manner that is associated with elevations in oxidative
stress and changes in the regulation of Akt, caspase-3 and Bax / Bcl-2 ratio.

Future directions
Previous work has suggested that nanoparticle size is an important determinant of
whether a particle may be toxic or not [45]. Based on this report and the data obtained in this
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study, future research directions could be aimed at understanding the potential interactive
effects that Y2O3 nanoparticle size and concentration may have on cell death.
How Y2O3 nanoparticles may increase cellular ROS levels and the effects that elevations
in ROS may have on cellular structure are not well understood. To address this gap in the
literature, future work employing electron microscopy could be undertaken to examine where
yttrium oxide nanoparticles may be located in the cell. Concurrent with these experiments,
other work could pursue how yttrium oxide exposure may affect cell size, mitochondrial
vacuolization, and whether these materials may affect the structure of the endoplasmic
reticulum. Similarly, other studies might investigate whether Y2O3 nanoparticle exposure is
associated with changes in the amount of lipid or protein oxidation.
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